Menatetrenone versus alfacalcidol in the treatment of Chinese postmenopausal women with osteoporosis: a multicenter, randomized, double-blinded, double-dummy, positive drug-controlled clinical trial
Yan Jiang,1,* Zhen-Lin Zhang,2,* Zhong-Lan Zhang,3 Han-Min Zhu,4 Yi-Yong Wu,5 Qun Cheng,4 Feng-Li Wu,5 Xiao-Ping Xing,1 Jian-Li Liu,3 Wei Yu,6 Xun-Wu Meng11Department of Endocrinology, Key Laboratory of Endocrinology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijin...
Guardado en:
Autores principales: | Jiang Y, Zhang ZL, Zhu HM, Wu YY, Cheng Q, Wu FL, Xing XP, Liu JL, Yu W, Meng XW |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1914110c98d9478986cdcba2c6582d5c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Anabolic Bone Stimulus Requires a Pre-Exercise Meal and 45-Minute Walking Impulse of Suprathreshold Speed-Enhanced Momentum to Prevent or Mitigate Postmenopausal Osteoporosis within Circadian Constraints
por: Qingyun Zheng, et al.
Publicado: (2021) -
A cross-sectional study exploring useful indicators for low bone mineral density in male alcoholic patients
por: Horai T, et al.
Publicado: (2018) -
Efficacy and safety of risedronate 150 mg once a month in the treatment of postmenopausal osteoporosis
por: Paula Rackoff
Publicado: (2009) -
The predictive role of monocyte-lymphocyte ratio and plateletlymphocyte ratio in postmenopausal osteoporosis
por: Ibrahim Kale
Publicado: (2021) -
The epidemiology and management of postmenopausal osteoporosis: a viewpoint from Brazil
por: Baccaro LF, et al.
Publicado: (2015)